Institutional investors hold a majority ownership of CBST through the 112.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2013, these large investors purchased a net $793.7 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINTSTATE CAPITAL LP Bought 975.9 Thousand shares of Cubist Pharmaceuticals In...
S.A.C. CAPITAL ADVISORS LP Bought 949.5 Thousand shares of Cubist Pharmaceuticals In...